Medifast Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 94.1% of US listed stocks.
MED's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 3,772.44 -- higher than 98.96% of US-listed equities with positive expected earnings growth.
The ratio of debt to operating expenses for Medifast Inc is higher than it is for about merely 5.97% of US stocks.
Stocks that are quantitatively similar to MED, based on their financial statements, market capitalization, and price volatility, are NSIT, GOOS, BMCH, LE, and AAP.
My first article on Medifast, Inc. (MED) was May 11th of this year. Like usually, I was analyzing MED because I wanted to see if I should add it to my portfolio or not. The issue was that, during the time of this analysis, I had to keep cash on...
Medifast, Inc. (MED) Q2 2020 Earnings Conference Call August 05, 2020 4:30 PM ET Company Participants Scott Van Winkle - Investor Relations Dan Chard - Chief Executive Officer Jim Maloney - Chief Financial Officer Conference Call Participants Kara Anderson - B. Riley Doug Lane - Lane Research Seb Barbero -...
Miller Value Partners recently released its Q2 2020 Investor Letter, a copy of which you can download here. The Opportunity Equity Fund posted a return of 47.02% for the quarter (net of fees), outperforming its benchmark, the S&P 500 Index which returned 20.54% in the same quarter. You should check out Miller Value Partners' top […]